Literature DB >> 15153944

Thrombotic microangiopathy after allogeneic bone marrow transplantation: a pathologic abnormality associated with diverse clinical syndromes.

J N George, G B Selby.   

Abstract

Entities:  

Mesh:

Year:  2004        PMID: 15153944     DOI: 10.1038/sj.bmt.1704513

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  7 in total

1.  Inhibitory autoantibodies against ADAMTS-13 in patients with thrombotic thrombocytopenic purpura bind ADAMTS-13 protease and may accelerate its clearance in vivo.

Authors:  S G Shelat; P Smith; J Ai; X L Zheng
Journal:  J Thromb Haemost       Date:  2006-08       Impact factor: 5.824

Review 2.  Hematopoietic stem cell transplant-associated thrombotic microangiopathy: current paradigm and novel therapies.

Authors:  J Khosla; A C Yeh; T R Spitzer; B R Dey
Journal:  Bone Marrow Transplant       Date:  2017-10-02       Impact factor: 5.483

Review 3.  Pathogenesis of thrombotic microangiopathies.

Authors:  X Long Zheng; J Evan Sadler
Journal:  Annu Rev Pathol       Date:  2008       Impact factor: 23.472

Review 4.  Diagnostic Testing for Differential Diagnosis in Thrombotic Microangiopathies

Authors:  Gina Zini; Raimondo De Cristofaro
Journal:  Turk J Haematol       Date:  2019-07-24       Impact factor: 1.831

Review 5.  Transplant-associated thrombotic microangiopathy: theoretical considerations and a practical approach to an unrefined diagnosis.

Authors:  Joanna A Young; Christopher R Pallas; Mary Ann Knovich
Journal:  Bone Marrow Transplant       Date:  2021-04-19       Impact factor: 5.174

Review 6.  The thrombotic microangiopathies.

Authors:  Lawrence Copelovitch; Bernard S Kaplan
Journal:  Pediatr Nephrol       Date:  2007-09-30       Impact factor: 3.714

Review 7.  Hematological Malignancies and Arterial Thromboembolism.

Authors:  Nathan Visweshwar; Michael Jaglal; Lubomir Sokol; Benjamin Djulbegovic
Journal:  Indian J Hematol Blood Transfus       Date:  2019-01-28       Impact factor: 0.900

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.